Q1 2022

Filed May 5, 2022 · 10-Q · 35 days after period end · 0001062822-22-000022

Q1 2022 · 10-Q

Revenue—

Net Income

-$23.48M

N/M vs Q1 2021

EPS, diluted—

Operating Income-$23,380,000N/M

Operating Cash Flow-$23,421,000N/M

Same quarter

Metric	Q1 2022	Q1 2021	Q1 2016	Q1 2015
Revenue	—	$0.00	$17.96M	$12.49M
Net Income	-$23.48M	-$20.96M	-$34.89M	-$34.88M
EPS Diluted	—	—	-$0.31	-$0.34

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR